HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 

Amgen NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Fri, 15 Feb 2019 07:41:21 GMTGoogle News
Amgen taps Abilita Bio's membrane protein technology  FierceBiotech

Amgen and Abilita Bio have inked a research deal in which Abilita will use its Enabled Membrane Protein platform to help Amgen work to develop drugs for ...

FierceBiotech
Amgen teams up with Abilita Bio in drug discovery  Seeking Alpha

Amgen ([[AMGN]]) will collaborate with privately held Abilita Bio to discover new drugs that target complex membrane proteins by leveraging the latter's En.

Seeking Alpha
Amgen: One Of The Best Dividend Growth Stocks In The Market Has Gone On Sale  Seeking Alpha

Amgen's shares yield more than 3% and offer some of the best dividend growth metrics in the market. Over the long term, this stock's performance has crushed ...

Seeking Alpha
Amgen (AMGN) Patent on Antibody is Invalid, US Agency Ruled, Sanofi (SNY), Regeneron (REGN) Win IPR Challenge - Bloomberg  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Amgen (NASDAQ: AMGN) Patent on Antibody is ...

StreetInsider.com
Amgen: Challenges Continue  Seeking Alpha

Amgen sees sales falling in 2019, due to real key patent expirations in combination with no more price hikes. This is disappointing as the company has seen ...

Seeking Alpha
Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019  Nasdaq

Amgen Inc. ( AMGN ) will begin trading ex-dividend on February 14, 2019. A cash dividend payment of $1.45 per share is scheduled to be paid on March.

Nasdaq
Amgen, Inc. (AMGN) Shares Bought by Cambridge Advisors Inc.  Fairfield Current

Cambridge Advisors Inc. grew its position in Amgen, Inc. (NASDAQ:AMGN) by 0.4% in the 4th quarter, according to its most recent 13F filing with the Securities ...

Fairfield Current
Amgen falls 3% after 2019 outlook falls short  CNBC

Amgen's results follow similar news from Pfizer earlier Tuesday, which also posted strong fourth-quarter results but issued weak 2019 guidance.

CNBC
Sizzling Technical Charts: Amgen Inc. (AMGN), Allergan plc (AGN)  Post Analyst

Amgen Inc. (NASDAQ:AMGN) recent gain occurred on low volume with 2149418 contracts changing hands on 13-Feb-19. That's down from its daily average of ...

Post Analyst
Amgen: This Industry Leader Remains Undervalued  Forbes

This stock looks expensive by traditional metrics, but our cash flow adjustments reveal that it's still cheap.

Forbes
Amgen Reports Q4: A Reanalysis  Seeking Alpha

AMGN reported a decent Q4; the stock dropped on guidance. Most of its product line is shrinking or getting old. The next year or two might see meaningful sales.

Seeking Alpha
Why Amgen Should Buy Alexion Pharmaceuticals  Barron's

Biotech giant Amgen may be on the prowl for an acquisition target, and Piper Jaffray's Christopher Raymond thinks that Alexion Pharmaceuticals could be a ...

Barron's
Amgen Leaves Investors With Mixed Emotions  Motley Fool

Amgen's (NASDAQ:AMGN) recently reported results for the fourth quarter of 2019 left investors feeling more mixed up than usual. Sales of important new ...

Motley Fool
Stocks making the biggest moves after hours: Apple, Amgen, AMD and more  CNBC

See which stocks are posting big moves after the bell on January 29.

CNBC
Amgen stock lower after earnings beat, lower guidance  MarketWatch

Shares of Amgen Inc. AMGN, +0.96% fell nearly 3% in the extended session Tuesday after the pharma company reported a quarterly beat but its 2019 ...

MarketWatch
Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva  Reuters

A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as ...

Reuters
Behind the Cutting Edge Technology: The History of Amgen  TheStreet.com

This biotechnology company got it's start California. Watch 'Behind the Label' TheStreet's new video series to learn more....AMGN.

TheStreet.com
Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?  Zacks.com

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next ...

Zacks.com
Amgen downgraded to in-line from outperform by Evercore ISI  MarketWatch

Shares of Amgen Inc. AMGN, -0.09% were down 1.4% in premarket trade Monday after the company was downgraded to in-line from outperform by Evercore ISI, ...

MarketWatch
Another big year at Amgen  Thousand Oaks Acorn

Buoyed by the success of two drugs in particular—Repatha, a cholesterol-lowering drug, and Prolia, which is used to treat osteoporosis— Thousand ...

Thousand Oaks Acorn
Technician reacts to Amgen earnings and what it means for biotech  CNBC

Amgen just reported earnings. A breakdown of the numbers, with Strategas' Chris Verrone, CNBC's Frank Holland and Melissa Lee, and the Fast Money traders, ...

CNBC
Biotech Giants Amgen and Biogen Fall on Earnings, Alzheimer’s News  Barron's

Big biotech stocks are having a bad day Wednesday, following muted guidance from Amgen (AMGN) and downbeat news about potential Alzheimer's ...

Barron's
Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60%  Xconomy

Regeneron Pharmaceuticals and partner Sanofi are cutting the list price of their heart drug alirocumab (Praluent) by 60 percent, the latest.

Xconomy
Amgen (AMGN) Gains But Lags Market: What You Should Know  Zacks.com

Amgen (AMGN) closed at $203.70 in the latest trading session, marking a +0.88% move from the prior day.

Zacks.com
FDA Panel Favors Amgen's Osteoporosis Treatment  Investor's Business Daily

An FDA committee voted to recommend Amgen's osteoporosis treatment — but not to women who are at risk of major cardiovascular events.

Investor's Business Daily
Amgen's migraine lead faces early test in CVS decision  BioPharma Dive

UPDATE: Jan. 30, 2019: Amgen on Tuesday disclosed fourth quarter sales numbers showing Aimovig earned the biotech $95 million in the three months from ...

BioPharma Dive
Amgen Inc. (AMGN) Ups & Downs Facts After Critical Volatility and volume Analysis  Investing News Update

Amgen Inc. (AMGN) try to takes its position in context of active momentum, while shares price fell -1.17% with the closing value of $186.76 during current trading ...

Investing News Update
Is Amgen Inc. (NASDAQ:AMGN) Valued Fairly At Current Levels?  Zeeland Press

Taking a look at Amgen Inc. (NASDAQ:AMGN)'s valuation level, we can focus on several ratios. One of the quickest ways to determine the projected value.

Zeeland Press
UnitedHealth's Optum to cover Amgen and Lilly migraine meds, Teva excluded  Seeking Alpha

UnitedHealth Group's (UNH -0.8%) pharmacy benefit manager Optum has added Amgen's (AMGN +0.2%) Aimovig (erenumab-aooe) and Eli Lilly's (LLY +0.8%) ...

Seeking Alpha
Amgen Inc. 2018 Q4 - Results - Earnings Call Slides  Seeking Alpha

The following slide deck was published by Amgen Inc. in conjunction with their 2018 Q4 earnings call.

Seeking Alpha
Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?  Zacks.com

While Amgen's (AMGN) growth drugs like Prolia & Xgeva may do well, biosimilar competition and slowdown in sales of mature products can put pressure on ...

Zacks.com
As Amgen (AMGN) Share Value Declined, Shareholder Centurylink Investment Management Company Has Decreased Holding by $306,774; As Coherent Com (COHR) Share Price Declined, Greatmark Investment Partners Cut Its Stake by $7.78 Million  The Hi New Ulm

Centurylink Investment Management Company decreased its stake in Amgen Inc (AMGN) by 10.69% based on its latest 2018Q3 regulatory filing with the SEC.

The Hi New Ulm
Amgen down 3% on Evercore downgrade  Seeking Alpha

Amgen (AMGN -3%) slips on below-average volume on the heels of a downgrade to neutral at Evercore ISI. Analyst Umer Raffat cites patent concerns for his ...

Seeking Alpha
Biotech Stock Roundup: Amgen, Vertex Get EC Nod for Label Expansion of Drugs  Zacks.com

A low key week for the biotech sector with regular drug approvals and pipeline updates.

Zacks.com
Riverpoint Capital Management Has Trimmed Its Amgen (AMGN) Holding by $2.53 Million; Shares Declined; Continental Advisors Stake in Waddell & Reed Finl (Call) (WDR) Has Lowered by $945,000 as Share Price Declined  The Hi New Ulm

Riverpoint Capital Management Llc decreased its stake in Amgen Inc (AMGN) by 79.07% based on its latest 2018Q3 regulatory filing with the SEC. Riverpoint ...

The Hi New Ulm
Amgen Reports Fourth Quarter And Full Year 2018 Financial Results  Yahoo! Finance News

THOUSAND OAKS, Calif., Jan. 29, 2019 /PRNewswire/ -- Amgen (AMGN) today announced financial results for the fourth quarter and full year 2018 in ...

Yahoo! Finance News
Meag Munich Ergo Kapitalanlagegesellschaft MBH Has $5.48 Million Holding in Amgen, Inc. (AMGN)  BharataPress

Meag Munich Ergo Kapitalanlagegesellschaft MBH trimmed its position in Amgen, Inc. (NASDAQ:AMGN) by 35.4% during the fourth quarter, according to its ...

BharataPress
Calico brings on Amgen's translational R&D head to lead early drug development  FierceBiotech

Amgen's head of translational medicine, Aarif Khakoo, M.D., is making the jump to Calico Life Sciences to head up drug development at Alphabet's ...

FierceBiotech
Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva  Nasdaq

NEW YORK, Feb 1- Optum, a top U.S. pharmacy benefit manager owned by UnitedHealth Group Inc, has included new migraine drugs from Amgen Inc and Eli.

Nasdaq
High-res genetic map by Amgen's deCODE offers new insight for disease research  FierceBiotech

With a new genetic map developed using whole-genome sequence data, scientists at Amgen's genomics research subsidiary deCODE Genetics have ...

FierceBiotech
Better Buy: Amgen vs. Johnson & Johnson  Motley Fool

It's a battle between a healthcare conglomerate and the granddaddy of biotech. Which is the better choice for investors today?

Motley Fool
Stocks Technical Analysis: Amgen Inc. (AMGN)  Voice Of Analysts

AMGN has a market cap of $119276.61M. Market capitalization refers to the total dollar market value of a company's outstanding shares. The company holds ...

Voice Of Analysts
Mixed Analyst Attention: Trinity Industries, Inc. (TRN), Amgen Inc. (AMGN)  Financial Mercury

The shares of Trinity Industries, Inc. (NYSE:TRN) has been pegged with a rating of Outperform by Cowen in its latest research note that was published on ...

Financial Mercury
Amgen Shows Rising Relative Price Performance; Still Shy Of Key Benchmark  Investor's Business Daily

In a welcome move, Amgen (AMGN) saw its Relative Strength Rating improve from 64 to 72 on Friday. X. Error loading player: No playable sources found.

Investor's Business Daily
Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market 2018-2025, Amgen Inc, Celgene Corp, F. Hoffmann-La Roche Ltd  SteerFeed

The Global “T Cell Surface Glycoprotein CD3 Epsilon Chain Market” report is a meticulous study of the global T Cell Surface Glycoprotein CD3 Epsilon Chain ...

SteerFeed
Amgen completes 5-year plan, sees 24% drop in facility footprint  BioProcess Insider

Amgen's commitment to next generation biomanufacturing has led to a reduction in its facility footprint of nearly a quarter since 2013. In 2013, Amgen ...

BioProcess Insider
Amgen's (AMGN) CEO Bob Bradway on Q4 2018 Results - Earnings Call Transcript  Seeking Alpha

Amgen Inc. (NASDAQ:AMGN) Q4 2018 Earnings Conference Call January 29, 2019 5:00 PM ET Company Participants Arvind Sood – Vice President-Investor ...

Seeking Alpha
Amgen Inc. (AMGN) expected to achieve 7.30% earnings growth for this year  Wallstreet Investorplace

To gauge your chances of picking a winning stock, take a close look at its fundamentals, especially its earnings-per-share growth. Earnings per share are ...

Wallstreet Investorplace
Amgen (AMGN) Announces EC Approves BLINCYTO in Patients With Philadelphia Chromosome Negative MRD-Positive B-cell Precursor ALL  StreetInsider.com

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Amgen (NASDAQ: AMGN) today announced that ...

StreetInsider.com
FDA advisory committees back Amgen's romosozumab  Seeking Alpha

In an 18 - 1 vote, two FDA advisory committees back approval of Amgen's (AMGN -0.1%) EVINITY (romosozumab) for the treatment of osteoporosis in ...

Seeking Alpha
Amgen (AMGN) Tops Q4 EPS by 14c; Guides FY19 Below the Street  StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

StreetInsider.com
Trading Update on Shares of Amgen Inc. (NASDAQ:AMGN): Week Performance is Currently -0.93310964  Felton News

When deciding how to best approach the stock market, individual investors may need to figure out what their time horizon is going to be. Short-term traders may.

Felton News
Amgen (AMGN) Receives NMPA Approval For Repatha in China  StreetInsider.com

Amgen (NASDAQ: AMGN) today announced that the National Medical Products Administration (NMPA) has approved a new indication for Repatha® ...

StreetInsider.com
Amgen Inc. (AMGN) and Atara Biotherapeutics Inc. (NASDAQ:ATRA) Contrasting side by side  Thе Mоnіtоr

Both Amgen Inc. (NASDAQ:AMGN) and Atara Biotherapeutics Inc. (NASDAQ:ATRA) are Biotechnology companies, competing one another. We will contrast their ...

Thе Mоnіtоr
COGs factor in Amgen's exit from $540m Advaxis deal  BioProcess Insider

Advaxis says Amgen's withdrawal from a 2016 personalized immuno-oncology partnership is due to portfolio rationalization, high cost of goods, and the ...

BioProcess Insider
Amgen and Allergan's Biosimilar to Rituxan Looks Good in Phase I/III Trial  BioSpace

Amgen and Allergan announced positive top-line results from a Phase I/Phase III trial of their biosimilar candidate, ABP 798, to Genentech and Biogen's Rituxan ...

BioSpace
Amgen (AMGN) PT Moves To $216 At Citi On Neulasta and Sensipar  StreetInsider.com

Citi analyst, Robyn Karnauskas, reiterated her Neutral rating on shares of Amgen (NASDAQ: AMGN) but raised her price target to $216 after fine tuning her ...

StreetInsider.com
Amgen announces details for 2019 race stage at Lake Tahoe  Tahoe Daily Tribune

Amgen has announced race details for its 2019 Tour of California, including a stage that will finish in South Lake Tahoe. Officials first announced the race would ...

Tahoe Daily Tribune
Erythropoietin Market 2019 – Amgen, Johnson & Johnson, Roche, Galenica, Emcure  Market Reports

The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2016 is about 58.53%.

Market Reports
Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN)  Nasdaq

Amgen Inc (Symbol: AMGN) has been named a Top Socially Responsible Dividend Stock by Dividend Channel , signifying a stock with above-average.

Nasdaq
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen  KFGO News

By Caroline Humer and Deena Beasley NEW YORK (Reuters) - CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs ...

KFGO News
Amgen adds bone drug Xgeva to pharma's cancer-related lineup on TV  FiercePharma

Another cancer drug has leapt onto the TV airwaves, although this time, it's a support player. Amgen's Xgeva, approved to treat cancer-related bone problems, ...

FiercePharma
Amgen Inc. (AMGN) and Scholar Rock Holding Corporation (NASDAQ:SRRK) Contrasting side by side  The Moveefy

This is a contrast between Amgen Inc. (NASDAQ:AMGN) and Scholar Rock Holding Corporation (NASDAQ:SRRK) based on their dividends, analyst ...

The Moveefy
Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen  Benzinga

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week highs Jan. 15) Adial ...

Benzinga
Amgen/Allergan's Rituxan Biosimilar Meets Goal in Phase III  Nasdaq

Amgen Inc. AMGN and partner Allergan plc AGN announced positive top-line results from a phase I/III study on the duo's biosimilar candidate,.

Nasdaq
Amgen Q4 2018 Earnings Preview  Seeking Alpha

Amgen (NASDAQ:AMGN) is scheduled to announce Q4 earnings results on Tuesday, January 29th, after market close. The consensus EPS Estimate is $3.28 ...

Seeking Alpha
Amgen's Aimovig reportedly excluded from CVS plans  Seeking Alpha

According to Reuters, CVS (CVS) has put new migraine drugs from Teva (TEVA) and Eli Lilly (LLY) on its list of covered medicines, while excluding Amgen's (

Seeking Alpha
Amgen cyclists will pass by Stockton Arena twice on Stage 3 route  Stockton Record

STOCKTON — The Amgen Tour of California is heading back to Stockton this year, with a few more twists and turns.Event owner and presenter AEG announced ...

Stockton Record
$-0.68 EPS Expected for Sientra, Inc. (SIEN); Bank Of The West Lowered Amgen (AMGN) Holding By $1.51 Million  The Hi New Ulm

Bank Of The West decreased Amgen Inc (AMGN) stake by 39.74% reported in 2018Q3 SEC filing. Bank Of The West sold 7,317 shares as Amgen Inc (AMGN)'s ...

The Hi New Ulm
Shakeup at the top of FDA's biosimilars division as Leah Christl departs for Amgen  Endpoints News

The FDA on Friday announced that Leah Christl, director of the Therapeutic Biologics and Biosimilars Staff (TBBS) in the Office of New Drugs (OND), has ...

Endpoints News
Coherus sues Amgen over Humira biosimilar  Seeking Alpha

Coherus BioSciences (CHRS +4.7%) has filed litigation against Amgen (AMGN -1.4%) claiming its Humira biosimilar, Amgevita, infringes on three U.S. Coherus ...

Seeking Alpha
Our Amgen Stock Prediction in 2019 (Up or Down)?  Investing Daily

The biotech sector can be risky, but it also can confer huge, rapid gains if you pick the right stock. Is drug maker Biogen on the cusp of a major breakout?

Investing Daily
Amgen Inc. (AMG) Plunged -0.74% on Feb 14  The EN Bulletin

Shares of Amgen Inc. (ETR:AMG) last traded at 165.69, representing a move of -0.74%, or -1.24 per share, on volume of 664 shares. After opening the trading ...

The EN Bulletin
Grandfield & Dodd Has Decreased Amgen (AMGN) Position; Richard Bernstein Advisors Has Increased International Business Machs (IBM) Holding By $1.58 Million  The Yomi Blog

Grandfield & Dodd Llc decreased Amgen Inc (AMGN) stake by 4.17% reported in 2018Q3 SEC filing. Grandfield & Dodd Llc sold 1492 shares as Amgen Inc ...

The Yomi Blog
Comparing of Amgen Inc. (AMGN) and NewLink Genetics Corporation (NASDAQ:NLNK)  The Hi New Ulm

Both Amgen Inc. (NASDAQ:AMGN) and NewLink Genetics Corporation (NASDAQ:NLNK) are each other's competitor in the Biotechnology industry. Thus the ...

The Hi New Ulm
Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgen's Humira Biosimilar Formulation  GlobeNewswire

Complaint alleges Amgen infringes three U.S. patents recently awarded to Coherus.

GlobeNewswire
Amgen Earnings: AMGN Stock Slips on Q4 Earnings Beat, Weak Q1 Guidance  Investorplace.com

Amgen earnings (AMGN) were better than what analysts were calling for after hours, but AMGN stock slid as the its guidance missed the mark.

Investorplace.com
Global Glucokinase Market Insights 2019-2025: Top Manufacturer Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA  Industry News Blog

The report on the global “Glucokinase market” studies the existing as well as the future visions of the global Glucokinase market. It includes a detailed outline of ...

Industry News Blog
Amgen Inc. (AMGN)- Stocks Rallying on Glossy Performance Valuation  NASDAQ Times

Amgen Inc. (NASDAQ:AMGN) traded under umbrella of Healthcare sector, shares slightly up 0.96% to trade at $186.00 in the last beat. By excluding these ...

NASDAQ Times
First Long Island Investors Increases Position in Amgen Com (AMGN); Northeast Financial Consultants Upped Its Magellan Midstream Partners LP (MMP) Holding by $557,373  The Yomi Blog

First Long Island Investors Llc increased its stake in Amgen Inc Com (AMGN) by 2.41% based on its latest 2018Q3 regulatory filing with the SEC. First Long ...

The Yomi Blog
Ticker Focus: Technical Signal Check on Shares of Amgen Inc (AMGN)  Martin Business Telegraph

Investors may be focusing on technical signals for Amgen Inc (AMGN). Looking at the reading from the 20-day moving average vs price signal, we can see that ...

Martin Business Telegraph
Capital Management Has Trimmed Stake in Amgen (AMGN) by $587,880 as Stock Price Declined; Asa Gold & Precious Metals LTD Decreased Its Stake in Royal Gold (RGLD) as Valuation Rose  The Moveefy

Capital Management Corp decreased its stake in Amgen Inc (AMGN) by 8.47% based on its latest 2018Q3 regulatory filing with the SEC. Capital Management ...

The Moveefy
Can Amgen Inc. (AMGN) Go the Extra Mile? Valuation in Focus as it Touches 114267068.9  Martin Business Telegraph

Amgen Inc. (AMGN) presently has an EV or Enterprise Value of 114267068.9. The EV helps show how the market assigns value to a company as a whole.

Martin Business Telegraph
Biosimilars Market Is Expected to Boom with Top Key Players Amgen Inc, Biocon, Dr. Reddy's Laboratories, F. Hoffmann-La Roche, Celltrion, Samsung Bioepis - Press Release  Digital Journal

The Global Biosimilars Market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by Report Consultant. It is expected to ...

Digital Journal
Amgen (AMGN) Holder Forte Capital Has Boosted Stake by $374,877 as Market Value Declined; As Ally Financial (ALLY) Valuation Declined, Snow Capital Management LP Trimmed Its Position by $4.38 Million  Thе Mоnіtоr

Forte Capital Llc increased its stake in Amgen Inc (AMGN) by 9.04% based on its latest 2018Q3 regulatory filing with the SEC. Forte Capital Llc bought 1811 ...

Thе Mоnіtоr
Expanded use for Amgen's Blincyto OK'd in Europe  Seeking Alpha

The European Commission approves the use of Amgen's (AMGN) BLINCYTO (blinatumomab) as monotherapy to treat adult patients with Philadelphia ...

Seeking Alpha
Silvercrest Asset Management Group Has Raised Its Amgen Com (AMGN) Stake by $7.25 Million; Synovus Financial Trimmed Its Lennar (LEN) Stake by $1.52 Million; Stock Value Declined  EN Digest

Silvercrest Asset Management Group Llc increased its stake in Amgen Inc Com (AMGN) by 12.64% based on its latest 2018Q3 regulatory filing with the SEC.

EN Digest
Auto-Injectors Market 2019 – Mylan, BD, Johnson & Johnson, Amgen Inc., Eli Lilly  Crypto News

The report on Auto-Injectors Market delivers executive summary along with data analysis of the current market scenario of Auto-Injectors. Report features ...

Crypto News
Comparison of Amgen Inc. (AMGN) and Cerus Corporation (NASDAQ:CERS)  The Yomi Blog

Both Amgen Inc. (NASDAQ:AMGN) and Cerus Corporation (NASDAQ:CERS) compete on a level playing field in the Biotechnology industry. We will evaluate ...

The Yomi Blog
Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod  Nasdaq

Amgen, Inc.AMGN and its partner UCB announced that an FDA advisory committee has given a positive recommendation to approve their pipeline candidate,.

Nasdaq
Lvm Capital Management LTD Has Cut Its Holding in Amgen (AMGN) as Market Value Declined; Curbstone Financial Management Stake in Amazon Com (Amzn) (AMZN) Lowered by $592,592  Thе Mоnіtоr

Lvm Capital Management Ltd decreased its stake in Amgen (AMGN) by 2.11% based on its latest 2018Q3 regulatory filing with the SEC. Lvm Capital ...

Thе Mоnіtоr
As Amgen (AMGN) Share Value Declined, Holder Mason Street Advisors Has Cut Its Stake by $506,943; As Sensata Technologies Holding (ST) Stock Price Declined, Markel Decreased by $4.21 Million Its Position  Lives Advice

Mason Street Advisors Llc decreased its stake in Amgen Inc (AMGN) by 2.62% based on its latest 2018Q3 regulatory filing with the SEC. Mason Street Advisors ...

Lives Advice
Amgen Inc. (NasdaqGS:AMGN) Enlivened Quant Data Under the Lens as PI Climbs to 0.97885  Tremont Herald

Investors are keeping a close eye on shares of Amgen Inc. (NasdaqGS:AMGN). The stock has a current six month price index of 0.97885. The six month price ...

Tremont Herald
Amgen, Sanofi back a round for real-world evidence platform tech; Daiichi Sankyo's pexidartinib secures speedy FDA review  Endpoints News

Aetion has garnered $27 million from a new venture round that includes some of the biggest names in healthcare. The company plans to use the cash to build ...

Endpoints News
Likely To Jump Soon? – Kohl's Corporation (KSS), Amgen Inc. (AMGN)  Financial Mercury

Looking at top Wall Street opinions, Kohl's Corporation (NYSE: KSS) has recently made its way into the research list of Telsey Advisory Group – signaling that ...

Financial Mercury
Icici Bk LTD (IBN) Shareholder Sarasin & Partners Llp Has Decreased Position; Brighton Jones Upped Its Position in Amgen (AMGN) as Market Value Declined  The Hi New Ulm

Sarasin & Partners Llp decreased its stake in Icici Bk Ltd (IBN) by 4.81% based on its latest 2018Q3 regulatory filing with the SEC. Sarasin & Partners Llp ...

The Hi New Ulm
Amgen reports strong fourth quarter income but weaker forecast for 2019  Pacific Coast Business Times

Regional biotech heavyweight Amgen reported increases in fourth quarter and full-year revenue Jan. 29, alongside strong increases in net income boosted by ...

Pacific Coast Business Times
A Deep Dive into the Insider Trading: Adobe Inc. (ADBE), Amgen Inc. (AMGN)  Financial Mercury

Looking at top Wall Street opinions, Adobe Inc. (NASDAQ: ADBE) has recently made its way into the research list of Stephens – signaling that their analyst's ...

Financial Mercury
Biotechnology Market Insight by 2024:Top Players- Agilent Technologies, Amgen, Abbott , Danaher, Illumina, PerkinElmer, Qiagen  openPR

Biotechnology Market size is set to exceed USD 775 billion by 2024.Growing incidence of chronic diseases will boost biotechnology market growth over the ...

openPR
Cornerstone Advisors Maintains Stake in Bemis (BMS); As Amgen (AMGN) Valuation Declined, Holder Blue Chip Partners Raised Stake  The Yomi Blog

Cornerstone Advisors Inc increased its stake in Bemis Inc (BMS) by 91.83% based on its latest 2018Q3 regulatory filing with the SEC. Cornerstone Advisors Inc ...

The Yomi Blog
 

Amgen Videos

Amgen
01:38:30
Amgen
Amgen CEO: Unmet Medical Needs | Mad Money | CNBC
16:18:20
Amgen CEO: Unmet Medical Needs | Mad Money | CNBC
The Future of Biotechnology
00:31:50
The Future of Biotechnology
2017 WMIF | 1:1 Fireside Chat: Robert Bradway, CEO, Amgen
16:02:32
2017 WMIF | 1:1 Fireside Chat: Robert Bradway, CEO, Amgen
Amgen’s Growing Immunotherapy Arsenal
15:28:26
Amgen’s Growing Immunotherapy Arsenal
Amgen Science
17:40:09
Amgen Science
The Amgen Difference
18:29:04
The Amgen Difference
BiTE® Immunotherapy: The Next Generation of Cancer Treatment
18:45:44
BiTE® Immunotherapy: The Next Generation of Cancer Treatment
Technician on Amgen earnings and what it means for biotech
23:10:49
Technician on Amgen earnings and what it means for biotech
Biotechnology by Amgen: Innovation
19:20:31
Biotechnology by Amgen: Innovation
 

Amgen Images

Bioengineering | Tufts University - Graduate Programs
Bioengineering | Tufts University - Graduate Programs
Amgen Tour of California 2014 - Podium Ambassadors Allison ...
Amgen Tour of California 2014 - Podium Ambassadors Allison ...
Jackie Crowell - Race For Life (Amgen Tour of California ...
Jackie Crowell - Race For Life (Amgen Tour of California ...
Flashcards Table on Oncology Drugs
Flashcards Table on Oncology Drugs
OCDgamer.dk: NBA Jam
OCDgamer.dk: NBA Jam
Amish Bishop Jacob Eash Cemetery Listing, Cambria County, PA
Amish Bishop Jacob Eash Cemetery Listing, Cambria County, PA
Osteoblasts and Osteoclasts - YouTube
Osteoblasts and Osteoclasts - YouTube
Vectibix - FDA prescribing information, side effects and uses
Vectibix - FDA prescribing information, side effects and uses
UV Protection Hat Skull Cap: UPF 50 Chrome Dome Caps
UV Protection Hat Skull Cap: UPF 50 Chrome Dome Caps
downtown Sonora CA | I think that just about every person ...
downtown Sonora CA | I think that just about every person ...
 

Amgen WebSites

 

Amgen Wiki

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.Amgen, which is one of the world's largest biotechnology companies, was established in Newbury Park, California in 1980, where its world headquarters are located. It had 5,125 employees in Thousand Oaks as of 2017, which made up 7.5% of the city's total employment. It is the largest employer in Ventura County. Amgen has attracted hundreds of scientists to the Newbury Park area. Focused on the cutting edge of molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.